Dallas, TXNCT07368946Now EnrollingIRB Ready

Chronic Kidney Disease (Stage 3-4) Clinical Trial in Dallas, TX

Access cutting-edge chronic kidney disease (stage 3-4) treatment through this clinical trial at a research site in Dallas. Study-provided care at no cost to qualified participants.

Sponsored by University of Texas Southwestern Medical Center

Quick Self-Assessment

See if you qualify for this Dallas location

Preparing your pre-screening questions…

Expert Care in Dallas

Access chronic kidney disease (stage 3-4) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related chronic kidney disease (stage 3-4) treatment provided free

Apply for This Dallas Location

Check if you qualify for this chronic kidney disease (stage 3-4) clinical trial in Dallas, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Dallas

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Dallas site if eligible
  4. 4Begin participation

About This Chronic Kidney Disease (Stage 3-4) Study in Dallas

The proposed pilot feeding study aims to explore novel pathways in phosphate metabolism and identify new biomarkers, as well as to develop a compound index for assessing phosphate overload with high validity and reliability. Investigators will address the following specific aims: 1). To explore novel pathways of phosphate metabolism and assess the influence of CKD status on these metabolic pathways. 2). To identify novel biomarkers for phosphate overload that reflect changes in dietary phosphorus intake. 3). To develop a compound phosphate overload index that measures dietary phosphorus intake with high validity and reliability. This study will provide novel insights into phosphate metabolism and the assessment of phosphate overload in CKD patients. This investigation aims to provide preliminary data to further studies for the development of reliable biomarkers in CKD patients, which could contribute significantly to early interventions and improve health outcomes.

Sponsor: University of Texas Southwestern Medical Center

Who Can Participate

Inclusion Criteria

Men or women aged 18 years or older, of any race/ethnicity
Women must either be post-menopausal or have no monthly menstrual cycle
Estimated total daily energy expenditure (TDEE) of 1700 - 2700 calories
eGFR \>15 ml/min/1.73m2 - \< 60 ml/min/1.73m2 for the CKD group (CKD Stage 3 or Stage 4)
eGFR ≥ 60 ml/min/1.73m2 and negative urine protein on dipstick test for the non-CKD group
English speaking

Exclusion Criteria

Pregnant, currently breastfeeding, or \<3 months postpartum
Current dialysis or kidney transplant patient
Current use of insulin or chemotherapy drugs
Smokes cigarettes or uses e-cigarettes (vapes)
Uses nicotine products or other recreational drugs
Medical history of stroke or myocardial infarction (MI)
Medical history of conditions that can affect phosphate metabolism (i.e., uncontrolled thyroid disorder, parathyroid disorder, or gastrointestinal malabsorption disorders \[Crohn's, ulcerative colitis, and celiac disease\], cirrhosis)
Current use of certain medications that directly alter phosphate levels (i.e., phosphate binders; phosphate supplements, irregular use of iron)
Regular use of laxatives
Hypo- or hyperphosphatemia (serum phosphate \< 2.5 or \> 4.6 mg/dl)
Hypo- or hypercalcemia (serum calcium \< 8.4 or \> 10.7 mg/dl)
Severe anemia (hemoglobin \< 8 g/dl for women and \< 9 g/dl for men)
Severe hyperglycemia (serum blood glucose \> 300 mg/dl)
Body weight less than \<110 lbs (due to risk for phlebotomy-induced anemia)
Received a blood transfusion in the last four months
Extreme hypertension as demonstrated by a blood pressure \> 180/120 as the average of 3 blood pressures taken during the screening/baseline, or extremely low blood pressure \< 80/50
Unwilling or unable to eat study meals
Lack of access to a functional refrigerator or freezer
Lack of access to a microwave or conventional oven
On low potassium diet
On low phosphate diet
Specific dietary restrictions (i.e. vegetarian, vegan, ketogenic, etc.)
Food allergies including but not limited to milk, egg, soy, nuts, shellfish, and wheat or gluten
Allergic to sodium phosphate
Unable or unwilling to complete urinary sample collection or food diaries
Unable or unwilling to provide informed consent
Unable to read or speak English
Participant in other conflict clinical trial
Unable to complete the study measurements
Unsafe to participate in this study per investigator's judgement

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Dallas?

Yes, this clinical trial (NCT07368946) has an active research site in Dallas, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Chronic Kidney Disease (Stage 3-4) Treatment Options in Dallas, TX

If you're searching for chronic kidney disease (stage 3-4) treatment options in Dallas, TX, this clinical trial (NCT07368946) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Dallas research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic kidney disease (stage 3-4) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all chronic kidney disease (stage 3-4) clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Dallas, TX

See all ankylosing spondylitis clinical trials recruiting in Dallas — not just this study.

Browse Ankylosing Spondylitis Trials in Dallas →

Browse More Trials by Condition

Ankylosing Spondylitis TrialsChronic Kidney Disease TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Dallas?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Dallas, TX